vs
Side-by-side financial comparison of EASTERN CO (EML) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.
EASTERN CO is the larger business by last-quarter revenue ($55.3M vs $38.3M, roughly 1.4× ImmunityBio, Inc.). EASTERN CO runs the higher net margin — 1.0% vs -161.8%, a 162.8% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs -22.4%). EASTERN CO produced more free cash flow last quarter ($3.1M vs $-71.3M).
EASTERN COEMLEarnings & Financial Report
China Eastern Airlines is a major airline in China, headquartered in Changning, Shanghai. It is one of the three major airlines in the country, along with Air China and China Southern Airlines.
ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.
EML vs IBRX — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $55.3M | $38.3M |
| Net Profit | $578.9K | $-61.9M |
| Gross Margin | 22.3% | 99.0% |
| Operating Margin | 3.1% | -169.0% |
| Net Margin | 1.0% | -161.8% |
| Revenue YoY | -22.4% | 407.0% |
| Net Profit YoY | 103.8% | -4.7% |
| EPS (diluted) | $0.10 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $38.3M | ||
| Q3 25 | $55.3M | $32.1M | ||
| Q2 25 | $70.2M | $26.4M | ||
| Q1 25 | $63.3M | $16.5M | ||
| Q4 24 | $64.3M | $7.6M | ||
| Q3 24 | $71.3M | $6.1M | ||
| Q2 24 | $72.6M | — | ||
| Q1 24 | $64.6M | — |
| Q4 25 | — | $-61.9M | ||
| Q3 25 | $578.9K | $-67.3M | ||
| Q2 25 | $3.4M | $-92.6M | ||
| Q1 25 | $1.9M | $-129.6M | ||
| Q4 24 | $1.3M | $-59.2M | ||
| Q3 24 | $-15.3M | $-85.7M | ||
| Q2 24 | $3.5M | — | ||
| Q1 24 | $1.9M | — |
| Q4 25 | — | 99.0% | ||
| Q3 25 | 22.3% | 99.4% | ||
| Q2 25 | 23.3% | 99.5% | ||
| Q1 25 | 22.4% | 99.6% | ||
| Q4 24 | 23.6% | — | ||
| Q3 24 | 25.5% | — | ||
| Q2 24 | 25.4% | — | ||
| Q1 24 | 23.9% | — |
| Q4 25 | — | -169.0% | ||
| Q3 25 | 3.1% | -173.5% | ||
| Q2 25 | 4.5% | -269.8% | ||
| Q1 25 | 5.1% | -390.1% | ||
| Q4 24 | 6.1% | -919.0% | ||
| Q3 24 | 9.5% | -1314.3% | ||
| Q2 24 | 8.3% | — | ||
| Q1 24 | 5.3% | — |
| Q4 25 | — | -161.8% | ||
| Q3 25 | 1.0% | -209.8% | ||
| Q2 25 | 4.9% | -350.3% | ||
| Q1 25 | 3.1% | -784.9% | ||
| Q4 24 | 2.0% | -783.4% | ||
| Q3 24 | -21.5% | -1404.0% | ||
| Q2 24 | 4.8% | — | ||
| Q1 24 | 3.0% | — |
| Q4 25 | — | $-0.06 | ||
| Q3 25 | $0.10 | $-0.07 | ||
| Q2 25 | $0.56 | $-0.10 | ||
| Q1 25 | $0.32 | $-0.15 | ||
| Q4 24 | $0.22 | $-0.08 | ||
| Q3 24 | $-2.46 | $-0.14 | ||
| Q2 24 | $0.56 | — | ||
| Q1 24 | $0.31 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $9.2M | $242.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $124.3M | $-500.5M |
| Total Assets | $220.0M | $501.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $242.8M | ||
| Q3 25 | $9.2M | $257.8M | ||
| Q2 25 | $9.1M | $153.7M | ||
| Q1 25 | $10.2M | $61.6M | ||
| Q4 24 | $16.1M | $149.8M | ||
| Q3 24 | $9.7M | $130.4M | ||
| Q2 24 | $2.0M | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $42.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $-500.5M | ||
| Q3 25 | $124.3M | $-524.3M | ||
| Q2 25 | $124.4M | $-570.7M | ||
| Q1 25 | $121.0M | $-591.4M | ||
| Q4 24 | $120.7M | $-489.1M | ||
| Q3 24 | $119.2M | $-745.1M | ||
| Q2 24 | $136.5M | — | ||
| Q1 24 | $134.5M | — |
| Q4 25 | — | $501.9M | ||
| Q3 25 | $220.0M | $519.0M | ||
| Q2 25 | $229.4M | $402.1M | ||
| Q1 25 | $232.3M | $303.8M | ||
| Q4 24 | $235.3M | $382.9M | ||
| Q3 24 | $244.2M | $364.6M | ||
| Q2 24 | $255.9M | — | ||
| Q1 24 | $253.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.35× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $3.1M | $-70.4M |
| Free Cash FlowOCF − Capex | $3.1M | $-71.3M |
| FCF MarginFCF / Revenue | 5.5% | -186.2% |
| Capex IntensityCapex / Revenue | 0.1% | 2.4% |
| Cash ConversionOCF / Net Profit | 5.38× | — |
| TTM Free Cash FlowTrailing 4 quarters | $12.3M | $-308.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-70.4M | ||
| Q3 25 | $3.1M | $-68.9M | ||
| Q2 25 | $3.8M | $-79.7M | ||
| Q1 25 | $-1.8M | $-85.9M | ||
| Q4 24 | $11.0M | $-85.1M | ||
| Q3 24 | $-2.9M | $-98.8M | ||
| Q2 24 | $8.4M | — | ||
| Q1 24 | $2.8M | — |
| Q4 25 | — | $-71.3M | ||
| Q3 25 | $3.1M | $-69.6M | ||
| Q2 25 | $3.0M | $-80.8M | ||
| Q1 25 | $-2.7M | $-87.0M | ||
| Q4 24 | $9.0M | $-87.3M | ||
| Q3 24 | $-7.7M | $-101.6M | ||
| Q2 24 | $7.3M | — | ||
| Q1 24 | $1.1M | — |
| Q4 25 | — | -186.2% | ||
| Q3 25 | 5.5% | -217.2% | ||
| Q2 25 | 4.3% | -305.9% | ||
| Q1 25 | -4.3% | -526.9% | ||
| Q4 24 | 13.9% | -1155.4% | ||
| Q3 24 | -10.8% | -1663.2% | ||
| Q2 24 | 10.1% | — | ||
| Q1 24 | 1.7% | — |
| Q4 25 | — | 2.4% | ||
| Q3 25 | 0.1% | 2.3% | ||
| Q2 25 | 1.1% | 4.1% | ||
| Q1 25 | 1.3% | 6.8% | ||
| Q4 24 | 3.2% | 28.0% | ||
| Q3 24 | 6.7% | 45.7% | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 2.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | 5.38× | — | ||
| Q2 25 | 1.09× | — | ||
| Q1 25 | -0.95× | — | ||
| Q4 24 | 8.41× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.40× | — | ||
| Q1 24 | 1.43× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.